Intrinsic Value of S&P & Nasdaq Contact Us

Zoetis Inc. ZTS NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$130.84
+8%
Analyst Price Target
$143.86
+18.8%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Zoetis Inc. (ZTS) has shown moderate revenue growth over the past 3 years, expanding from $8.1B to $9.5B (average +5.5%/yr). Net income reached $2.7B, reflecting solid earnings growth at +8.2%/yr on average. The net profit margin is 28.2%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 70.5% (high), with a +0.9pp trend over the period. With a $51B market cap and MOAT composite score of 76/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (65/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 17-year history, the company was profitable in 16 of 17 years — an excellent long-term track record
  • INCOME (85/100, Pass) — proves strong profitability and pricing power
  • MOAT (76/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 71/100 with 4/7 criteria passed.

71/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
58/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $6.02
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
Score: 76/100
GM 70.5% (+0.9pp)
Proven by this page
GROWTH
65/100
Rev +5.5%/yr
NI +8.2%/yr
Proven by this page
INCOME
85/100
Margin 28.2%
$9.5B
Proven by this page
Zoetis Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $9.47B$9.47B$9.26B$8.54B$8.08B
Gross Profit $6.71B$6.67B$6.54B$5.83B$5.63B
Gross Margin 70.8%70.5%70.6%68.3%69.6%
Operating Income $3.6B$3.6B$3.39B$3.07B$2.89B
Net Income $2.67B$2.67B$2.49B$2.34B$2.11B
Net Margin 28.2%28.2%26.9%27.4%26.2%
EPS (Diluted) $6.02$6.02$5.47$5.07$4.49
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message